From CDC-Authored Genomics Publication Database
This database contains CDC-authored publications in public health genomics including infectious diseases, newborn screening, reproductive health, genetic testing, cancer, chronic diseases, birth defects and developmental disabilities, environmental and occupational health as well as laboratory, bioinformatics and statistical methods.
- Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.
Ezewudo Matthew et al. Scientific reports 2018 Oct 8(1) 15382 - Towards national systems for continuous surveillance of antimicrobial resistance: Lessons from tuberculosis.
Suthar Amitabh B et al. PLoS medicine 2018 Sep (9) e1002658 - Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex.
Brown-Elliott Barbara A et al. International journal of systematic and evolutionary microbiology 2018 Sep - Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
Kandler Justin L et al. Antimicrobial agents and chemotherapy 2018 Aug - Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis.
Auld Sara C et al. Respirology (Carlton, Vic.) 2018 Jun - The California Multidrug-Resistant Tuberculosis Consult Service: a partnership of state and local programs.
Shah N S et al. Public health action 2018 Mar 8(1) 7-13 - Statistical Method to Detect Tuberculosis Outbreaks among Endemic Clusters in a Low-Incidence Setting.
Althomsons Sandy P et al. Emerging infectious diseases 2018 Mar (3) 573-575 - Detection of Apparent Cell-free M. tuberculosis DNA from Plasma.
Click E S et al. Scientific reports 2018 Jan (1) 645 - A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.
Miotto Paolo et al. The European respiratory journal 2017 Dec (6) - Drivers of Tuberculosis Transmission.
Mathema Barun et al. The Journal of infectious diseases 2017 Nov (suppl_6) S644-S653 - Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
Auld Sara C et al. The Journal of infectious diseases 2017 Nov (suppl_6) S662-S668 - Detection of Mycobacterium tuberculosis pncA mutations by the NIPRO Genoscholar(™)·PZA-TB II as compared to conventional sequencing.
Willby Melisa J et al. Antimicrobial agents and chemotherapy 2017 Oct - Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.
Boyd R et al. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2017 Nov 21(11) 1173-1180 - Impact of Larger Sputum Volume on Xpert(®) MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.
Badal-Faesen Sharlaa et al. Journal of clinical medicine 2017 Aug 6(8) - Solid Organ Transplant-Transmitted Tuberculosis Linked to a Community Outbreak - California, 2015.
Kay Alexander et al. MMWR. Morbidity and mortality weekly report 2017 Aug (30) 801-805 - Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa.
Magee Matthew J et al. PloS one 2017 (7) e0180916 - Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.
J-Y Feng J-Y et al. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2017 May - Evaluation of Automated Molecular Testing Rollout for Tuberculosis Diagnosis Using Routinely Collected Surveillance Data - Uganda, 2012-2015.
Scott Colleen et al. MMWR. Morbidity and mortality weekly report 2017 Mar (12) 339-342 - pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.
Allana Salim et al. Emerging infectious diseases 2017 Mar (3) 491-495 - Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.
Shah N Sarita et al. The New England journal of medicine 2017 Jan (3) 243-253 - Molecular, Spatial, and Field Epidemiology Suggesting TB Transmission in Community, Not Hospital, Gaborone, Botswana.
Surie Diya et al. Emerging infectious diseases 2017 Mar 23(3) 487-490 - Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions.
Teeter Larry D et al. BMC infectious diseases 2016 Oct (1) 594 - Xpert MTB/RIF Assay shows faster clearance of M. tuberculosis DNA with higher rifapentine exposure.
Jayakumar A et al. Journal of clinical microbiology 2016 Oct - Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003-2013.
Shah Neha S et al. Open forum infectious diseases 2016 Sep 3(3) ofw150 - Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?
Auld Andrew F et al. Transactions of the Royal Society of Tropical Medicine and Hygiene 2016 Sep - Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Nahid Payam et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 Oct 63(7) 853-67 - Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Nahid Payam et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 Aug - Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States.
Yakrus Mitchell A et al. Tuberculosis research and treatment 2016 3404860 - Human tuberculosis caused by Mycobacterium bovis in the United States, 2006-2013.
Scott Colleen et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 Jun - Protocol for a population-based molecular epidemiology study of tuberculosis transmission in a high HIV-burden setting: the Botswana Kopanyo study.
Zetola N M et al. BMJ open 2016 (5) e010046 - Possible Airborne Person-to-Person Transmission of Mycobacterium bovis - Nebraska 2014-2015.
Buss Bryan F et al. MMWR. Morbidity and mortality weekly report 2016 (8) 197-201 - Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.
Farhat Maha R et al. American journal of respiratory and critical care medicine 2016 Feb - Representativeness of Tuberculosis Genotyping Surveillance in the United States, 2009-2010.
Shak Emma B et al. Public health reports (Washington, D.C. : 1974) 130(6) 596-601 - Rv3351c, a Mycobacterium tuberculosis gene that affects bacterial growth and alveolar epithelial cell viability.
Pavlicek Rebecca L et al. Canadian journal of microbiology 2015 Oct 1-10 - A Field-Validated Approach Using Surveillance and Genotyping Data to Estimate Tuberculosis Attributable to Recent Transmission in the United States.
France Anne Marie et al. American journal of epidemiology 2015 Nov (9) 799-807 - A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis.
Nicol Mark Patrick et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 Oct (suppl 3) S164-S172 - Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform.
Starks Angela M et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 Oct S141-6 - Mycobacterium tuberculosis pncA polymorphisms that do not confer pyrazinamide resistance at a breakpoint concentration of 100 µg/ml in MGIT.
Whitfield M G et al. J. Clin. Microbiol. 2015 Aug 19. - Evaluation of a u.s. Public health laboratory service for the molecular detection of drug resistant tuberculosis.
Yakrus Mitchell A et al. Tuberc Res Treat 2015 701786 - Defining the needs for next generation assays for tuberculosis.
Denkinger Claudia M et al. J. Infect. Dis. 2015 Apr 1. S29-38 - Genomic epidemiology of multidrug-resistant Mycobacterium tuberculosis during transcontinental spread.
Coscolla Mireia et al. J. Infect. Dis. 2015 Jan 18. - Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis.
Reeves Analise Z et al. Antimicrob. Agents Chemother. 2015 Jan 59(1) 444-9 - Notes from the field: use of genotyping to disprove a presumed outbreak of Mycobacterium tuberculosis - Los Angeles County, 2013-2014.
Baker Brian J et al. MMWR Morb. Mortal. Wkly. Rep. 2014 Oct 10. 63(40) 907-8 - Antimycobacterial activity of DNA intercalator inhibitors of Mycobacterium tuberculosis primase DnaG.
Gajadeera Chathurada et al. J. Antibiot. 2015 Mar 68(3) 153-7 - Multicenter feasibility study to assess external quality assessment panels for Xpert MTB/RIF assay in South Africa.
Scott Lesley et al. Journal of clinical microbiology 2014 Jul (7) 2493-9 - Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States.
Yakrus Mitchell A et al. J. Clin. Microbiol. 2014 Jun 52(6) 1932-7 - Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use - United States, 2013.
et al. MMWR Morb. Mortal. Wkly. Rep. 2013 Oct 18. 62(41) 821-7 - Shared Mycobacterium avium genotypes observed among unlinked clinical and environmental isolates.
Dirac M Ashworth et al. Appl. Environ. Microbiol. 2013 Sep 79(18) 5601-7 - Prioritizing tuberculosis clusters by genotype for public health action, Washington, USA.
Lindquist Scott et al. Emerging Infect. Dis. 2013 Mar 19(3) 493-6 - Use of whole genome sequencing to determine the microevolution of Mycobacterium tuberculosis during an outbreak.
Kato-Maeda Midori et al. PLoS ONE 2013 8(3) e58235 - Using routinely reported tuberculosis genotyping and surveillance data to predict tuberculosis outbreaks.
Althomsons Sandy P et al. PLoS ONE 2012 7(11) e48754 - New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
Malik Seidu et al. PLoS ONE 2012 7(6) e39754 - Using genotyping and geospatial scanning to estimate recent mycobacterium tuberculosis transmission, United States.
Moonan Patrick K et al. Emerging Infect. Dis. 2012 Mar 18(3) 458-65 - Multistate outbreak of MDR TB identified by genotype cluster investigation.
Barry Pennan M et al. Emerging Infect. Dis. 2012 Jan 18(1) 113-6 - Tuberculosis genotyping information management system: enhancing tuberculosis surveillance in the United States.
Ghosh Smita et al. Infect. Genet. Evol. 2012 Jun 12(4) 782-8 - Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
Boehme Catharina C et al. Lancet 2011 Apr 30. 377(9776) 1495-505
.png)
No hay comentarios:
Publicar un comentario